Submitted by John Stauber on
Stephanie Saule reports that "Innerstate, a documentary about three people coping with disabling chronic illness, may be coming to a theater near you. If so, admission will be free, courtesy of the drug maker that produced the film. The 58-minute film ... is an unusual form of soft-pedal marketing of a blockbuster drug, Remicade.
Submitted by Bob Burton on
Patrick Moore, a former environmental activist who left Greenpeace twenty years ago and is now a PR consultant, argues "it is now far more effective to work with governments and industries to encourage positive change." As a consultant, Moore has dismissed concerns about the impact of logging in the Amazon, supported Newmont Mining over controversies at its mines in the U.S., Ghana and Peru, defended the use of PVC in plastics and e
Submitted by Bob Burton on
A doctor who featured in the PR plans of the drug company GlaxoSmithKline has been appointed by the U.S. Food and Drug Administration to a committee reviewing possible links between anti-depressant drugs and suicidality. In December 2004, internal GlaxoSmithKline documents revealed that Dr.
Submitted by Bob Burton on
Citing instances where groups like Citizens Against Government Waste and Americans for Tax Reform have accepted corporate funding to lobby for their donors' causes, journalist Bill Adair explores whether greater disclosure by non-profit groups is warranted.
Submitted by Diane Farsetta on
Submitted by Bob Burton on
Alan Cassels notes that disease mongering advertisements for cholesterol-lowering drugs, such as for Pfizer's Lipitor, hype the risk of heart attacks for those people with 'high' cholesterol.
Submitted by Diane Farsetta on
According to a report by the U.S.
Submitted by Diane Farsetta on
On its "Weekend Edition Saturday" show, NPR aired a segment titled, "Environmentalists Rethink Stance on Nuclear Power." Who was their one example of an environmentalist turned nuclear power proponent? None other than Greenpeace co-founder turned industry flack Patrick Moore.
Submitted by Jonathan Rosenblum on
Americans may tire quickly of some pharmaceutical PR, but they've got nowhere to turn (certainly not in bed) when it comes to a new campaign sponsored by the makers of a sleep-fighting medication, Provigil. Drug-maker Cephalon hired Dorland Global Public Relations, which has spun consumers' disinterest in "sleepiness" into a Homeland Security-like campaign for "alertness." The trick: target employers.
Submitted by Bob Burton on
GlaxoSmithKline breached the British drug industry's own self-regulatory code of conduct by promoting ropinirole to treat restless legs syndrome before the drug had been approved for that use.
Center for Media and Democracy (CMD)
520 University Ave, Ste 305 • Madison, WI 53703 • (608) 260-9713
CMD is a 501(c)(3) tax-exempt non-profit.
© 1993-2024